tiprankstipranks
Sanofi (MX:SNYN)
:SNYN
Mexico Market
SNYN
Sanofi
RESEARCH TOOLSreports

Sanofi (SNYN) Stock News & Sentiment

0 Followers
Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials
Premium
Market News
Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials
10d ago
NVS
SNY
Sanofi: Balanced Risk-Reward as Pipeline Setbacks and Dupixent LOE Temper Growth Outlook, With BD/M&A Execution Key to Equity Story
Premium
Ratings
Sanofi: Balanced Risk-Reward as Pipeline Setbacks and Dupixent LOE Temper Growth Outlook, With BD/M&A Execution Key to Equity Story
11d ago
SNY
Sanofi Extends Lunsekimig COPD Program With Long-Term Safety Study
Premium
Company Announcements
Sanofi Extends Lunsekimig COPD Program With Long-Term Safety Study
14d ago
SNY
Sanofi and Blueprint Advance First-in-Human Pan-KRAS Cancer Trial, Eyeing New Oncology Upside
Premium
Company Announcements
Sanofi and Blueprint Advance First-in-Human Pan-KRAS Cancer Trial, Eyeing New Oncology Upside
18d ago
SNY
Sanofi’s New H5N8 Flu Vaccine Trial Signals Long-Term Pandemic Preparedness Play
Premium
Company Announcements
Sanofi’s New H5N8 Flu Vaccine Trial Signals Long-Term Pandemic Preparedness Play
21d ago
SNY
Sanofi Wins EU Approval to Use MenQuadfi in Infants From Six Weeks
Premium
Company Announcements
Sanofi Wins EU Approval to Use MenQuadfi in Infants From Six Weeks
1M ago
6K
SNY
Regeneron and Sanofi Terminate Real‑World Dupilumab Study in Chronic Urticaria
Premium
Company Announcements
Regeneron and Sanofi Terminate Real‑World Dupilumab Study in Chronic Urticaria
1M ago
SNY
REGN
More MX:SNYN News >

SNYN News on the Web

RBC Capital Initiates a Hold Rating on Sanofi (SNYNF)
TipRanks News
Neutral
Bank of America Securities Remains a Hold on Sanofi (SNYNF)
TipRanks News
Neutral
Eli Lilly to Buy Immunology Biotech Merida Biosciences in $2.9B Deal
Zacks
Neutral
Top Stock Reports for NVIDIA, ExxonMobil & HSBC
Zacks
Neutral
Teva Rises 17% YTD: Should You Buy, Sell or Hold the Stock?
Zacks
Neutral
Sanofi (SNYNF) Gets a Hold from UBS
TipRanks News
Bearish
Why the Amlitelimab Setback Isn’t Enough to Sink Sanofi’s Multi-Billion Dollar Engine
Insider Monkey
Neutral
Sanofi Wins EU Approval to Use MenQuadfi in Infants From Six Weeks
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
MX:SNYN
Sector Average
Media Buzz
This Week8 articles
Weekly Average6.25 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:SNYN’s Media Buzz Sentiment?
8 articles about MX:SNYN were published this week. In an average week, 6.25 articles are published.
    What is MX:SNYN’s weekly average amount of articles?
    In an average week, 6.25 articles about MX:SNYN are published.
      What is MX:SNYN’s News Sentiment?
      50% of articles about MX:SNYN were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        NTLAIntellia Therapeutics
        BAYRYBayer
        GHGuardant Health
        ROIVRoivant Sciences
        CMPSCOMPASS Pathways
        Showing the stocks with the most bullish news sentiment over the past week